Fosfomycin in vitro resistance of Escherichia coli from the community

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 1, 2011, Pages 96-

  Biondo, Caroline M ^a   Rocha, Jaime L ^b   Tuon, Felipe Francisco ^c  

^a Hospital Universitário de Curitiba FEMPAR   (Brazil)

^b Division of Microbiology   (Brazil)

^c HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CIPROFLOXACIN; FOSFOMYCIN; LEVOFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; BRAZIL; ENTEROCOCCUS; ESCHERICHIA COLI; LETTER; NONHUMAN;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FOSFOMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS;

EID: 79955967888     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702011000100021     Document Type: Letter

References (4)

1. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20 2010, CLSI, Clinical and Laboratory Standards Institute, Wayne, PA.
2. Popovic M., Steinort D., Pillai S., Joukhadar C. Fosfomycin: an old, new friend?. Eur J Clin Microbiol Infect Dis 2010, 29:127-142.
3. Calbo E., Romani V., Xercavins M., et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother 2006, 57:780-783.
4. Superti S., Dias C.A., d'Azevedo P.A. In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis. Braz J Infect Dis 2009, 13:123-124.